ProfileGDS4718 / 1557575_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 33% 30% 25% 23% 25% 18% 12% 32% 26% 29% 28% 32% 18% 18% 15% 24% 21% 19% 19% 12% 27% 26% 25% 28% 23% 19% 29% 18% 17% 21% 21% 23% 26% 17% 22% 17% 19% 25% 31% 25% 28% 17% 17% 21% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6585733
GSM549102patient 115, normal, homogenized [OPG study]4.5620830
GSM549104patient 119, normal, homogenized [OPG study]4.2950625
GSM549108patient 138, normal, homogenized [OPG study]4.2785523
GSM549119patient 077, normal, homogenized [OPG study]4.3253925
GSM549133patient 032, cancer, homogenized [OPG study]4.0358418
GSM549139patient 042, cancer, homogenized [OPG study]3.8358212
GSM549099patient 107, normal, homogenized [OPG study]4.6503232
GSM549109patient 139, normal, homogenized [OPG study]4.3908626
GSM549110patient 046, normal, homogenized [OPG study]4.519529
GSM549114patient 063, normal, homogenized [OPG study]4.430128
GSM549122patient 082, normal, homogenized [OPG study]4.6244232
GSM549134patient 033, cancer, homogenized [OPG study]4.0620218
GSM549136patient 036, cancer, homogenized [OPG study]4.001318
GSM549140patient 044, cancer, homogenized [OPG study]3.9280715
GSM549111patient 047, normal, homogenized [OPG study]4.2702124
GSM549113patient 057, normal, homogenized [OPG study]4.1168621
GSM549132patient 031, cancer, homogenized [OPG study]4.0864219
GSM549137patient 038, cancer, homogenized [OPG study]4.1121919
GSM549142patient 047, cancer, homogenized [OPG study]3.9155812
GSM549100patient 110, normal, homogenized [OPG study]4.4422627
GSM549107patient 135, normal, homogenized [OPG study]4.3493726
GSM549115patient 068, normal, homogenized [OPG study]4.2836125
GSM549116patient 072, normal, homogenized [OPG study]4.4341828
GSM549120patient 078, normal, homogenized [OPG study]4.2700423
GSM549131patient 030, cancer, homogenized [OPG study]4.057419
GSM549118patient 074, normal, homogenized [OPG study]4.5161829
GSM549129patient 027, cancer, homogenized [OPG study]4.0868718
GSM549123patient 088, normal, homogenized [OPG study]4.0263717
GSM549124patient 006, cancer, homogenized [OPG study]4.2376321
GSM549126patient 015, cancer, homogenized [OPG study]4.1646121
GSM549128patient 025, cancer, homogenized [OPG study]4.2294223
GSM549103patient 117, normal, homogenized [OPG study]4.4299526
GSM549117patient 073, normal, homogenized [OPG study]4.0267417
GSM549138patient 041, cancer, homogenized [OPG study]4.2058622
GSM549141patient 045, cancer, homogenized [OPG study]3.9857917
GSM549130patient 028, cancer, homogenized [OPG study]4.1139919
GSM549101patient 111, normal, homogenized [OPG study]4.3626425
GSM549105patient 128, normal, homogenized [OPG study]4.5893431
GSM549106patient 134, normal, homogenized [OPG study]4.2748225
GSM549112patient 048, normal, homogenized [OPG study]4.4524628
GSM549125patient 011, cancer, homogenized [OPG study]4.0376417
GSM549127patient 024, cancer, homogenized [OPG study]4.0086817
GSM549135patient 035, cancer, homogenized [OPG study]4.1300721